NTR Nutrien Ltd
$70.66
▲ 1.6%Updated Oct 16, 2:25 PM ET
Report Card
NTR at a glance — five pillars scored 0–100 from real filed financials.
How the 0–100 rating is calculatedOverall: Favorable · 63/100. A wider, greener shape means more pillars look healthy. Dividends scores 0 when a company pays none — that is a choice, not a flaw.
Price — Past Year
▲ Up 7.7% in the year to Jul 6, 2026
Key Metrics
Market Cap
$32.21B
P/E
13.05x
Forward P/E (est.)
9.32x
ROE
9.5%
Revenue Growth
8.4%
EPS Growth
360.8%
Profit Margin
8.6%
FCF Yield
18.3%
Debt / Equity
0.47x
ROIC
9.0%
Interest Coverage
5.01x
Current Ratio
1.34x
Dividend Yield
3.4%
Implied Growth (rev. DCF)
2.3%
Rating Score
63/100
Business Overview
Nutrien Ltd (NTR) is a large-cap NYSE-listed company in the Chemicals industry, within the Materials sector, with a market value around $32.21B.
In its latest reported year it generated about $26.89B in revenue and $2.30B in net profit.
Our model rates NTR Favorable (63/100) on growth, profitability, financial health, and valuation. The summary below is built from its filed financials and current ratios and refreshes automatically.
Economic Moat
Evidence of durable competitive advantage in the filed financials (9 years of history).
Profit margins and economic moats, explainedThe numbers don't show a durable competitive advantage — margins, growth, or returns on capital have been unstable or thin. Great returns are still possible; they just aren't protected.
29.7% average over the last 3 years
±6.5 pts around 28.8% across 9 years
grew in 6 of the last 8 year-over-year periods
positive in 9 of 9 years
9.0% latest fiscal year
A moat can't be proven by numbers alone — this scores the evidence a durable advantage leaves behind (pricing power, consistency, returns on capital), computed the same way for every stock. Pair it with the business overview before concluding anything.
Technical Analysis (Educational)
Technical analysis reads price and volume to judge momentum and timing. It complements the fundamentals above — it does not replace them. Here is what NTR's chart says today, with each tool explained.
Trend — moving averages. A moving average is the average closing price over a window, which smooths out daily noise. NTR trades near $70.66, above its 50-day average ($68.46) and 200-day average ($66.10). Price above both averages, with the shorter one above the longer, is the textbook definition of an uptrend — momentum favours buyers.
Momentum — RSI. The Relative Strength Index runs 0–100 and measures how strong recent gains are versus losses. Above 70 is "overbought", below 30 "oversold". At 38 it is in neutral territory — neither stretched nor washed out.
MACD. MACD compares two moving averages to flag shifts in momentum. Its histogram is currently positive — short-term momentum is improving.
Volatility — ATR. Average True Range is the typical daily move. NTR's is $1.53 (~2.2% of price), so swings of about that size each day are normal — handy for setting a stop that isn't too tight.
Support & resistance. In the month to Jul 6, 2026, NTR found buyers near $59.72 (support) and sellers near $69.00 (resistance); its 52-week range then was $53.03–$85.36. A decisive break beyond either edge often marks the next move.
Volume. The latest session traded 0.3× the 20-day average — lighter than usual, so the move carries less conviction. Rising volume on up-days suggests real buying; on down-days, real selling.
Educational information to help you read a chart — not a recommendation or a forecast. The indicators were last computed on Jul 6, 2026; the price is current.
Revenue Growth
4Y CAGR
-0.8%
Revenue moved from $4.55B in 2017 to $26.89B in 2025, a 24.9% compound annual growth rate. The most recent year grew a steady 8.4% year over year. Slower, mature growth is common for established businesses.
Profitability
Gross Margin
31.0%
Operating Margin
13.9%
Net Margin
8.5%
ROE
9.5%
Nutrien Ltd keeps about 8.6% of each sales dollar as net profit, with a 31.0% gross margin and 13.9% operating margin. Return on equity is 9.5% and return on invested capital about 9.0%. Margins are moderate — typical of a competitive but profitable business.
Debt Analysis
Total Debt
$9.35B
Net Debt
$8.65B
Net Debt / EBITDA
2.32x
Debt / Equity
0.47x
Leverage: debt-to-equity is 0.5x, and operating profit covers interest about 5.0x, with a current ratio of 1.3x. That is a conservative balance sheet — a cushion in downturns. It carries roughly $9.35B of total debt against $701.00M of cash.
Cash Flow Analysis
Operating CF
$4.01B
Free Cash Flow
$2.13B
FCF Margin
7.9%
In the latest year Nutrien Ltd produced about $4.01B of operating cash flow and $2.13B of free cash flow after capital spending. That is a free-cash-flow yield of about 18.3% on today's price. Strong cash generation funds dividends, buybacks, and reinvestment.
Dividend Safety
Can the payout survive a bad year? Scored from filed cash flow, earnings coverage, and the raise/cut record.
What to look for in a dividend stockThe payout is comfortably covered by cash the business actually generates, with a raise habit behind it.
Dividend yield
3.4%
Per share (latest FY)
$2.16
Total paid (latest FY)
$1.06B
History on record
9 years
dividend uses 50% of free cash flow
46% of net income paid out
total dividends increased 3 years in a row
no cuts in the last 9 years on record
Coverage uses the latest fiscal year as filed with the SEC; the streak counts total dollars paid (per-share figures can carry split artifacts). Educational information, not income advice.
Valuation Analysis
P/E
13.05x
P/S
1.16x
P/B
1.15x
EV / EBITDA
6.69x
NTR trades at 13.1x trailing earnings (about 9.3x on estimated forward earnings), 1.2x sales, and 1.2x book value. Reverse-engineering today's price implies the market expects roughly 2.3% long-term free-cash-flow growth. That is an undemanding multiple — potentially cheap if the business is stable.
DCF Fair Value (Educational)
A two-stage discounted cash flow on real SEC-filed free cash flow — the intrinsic-value anchor professional analysts triangulate from.
How this DCF estimate is calculatedDCF fair value / share
$81.89
Current price
$70.66
Starting FCF (latest 10-K)
$2.13B
Growth, years 1–5
8.4%
Fade to terminal, years 6–10
2.5%
Discount rate
9.0%
Cash flows grow at the stage-1 rate (trailing revenue growth, capped at 20%) for five years, fade to 2.5% by year 10, and continue at that rate forever (Gordon terminal value), all discounted at 9.0%. Small changes in assumptions move the result a lot — treat this as one reference point, not a target price. Educational only, not investment advice.
Metrics vs. Sector Range
Where NTR sits versus the Materials companies we cover.
Bands show the middle half (25th–75th percentile) of the 54 Materials companies in our coverage that have fundamentals data — the peer-relative anchor professional comps analysis uses. Context only — not investment advice.
Sector Peer Comparison
How NTR stacks up against its Materials peers — valuation, profitability, and growth versus the sector median.
Among the 54 rated Materials companies we cover, NTR ranks #20 by our overall rating. It trades at a discount versus the sector on earnings (13.1x P/E vs. 20.1x median) with a lower return on equity (9.5% vs. 16.1%) and faster revenue growth (8.4% vs. 7.9%).
P/E vs sector
13.1x
median 20.1x
ROE vs sector
9.5%
median 16.1%
Growth vs sector
8.4%
median 7.9%
Sector rank
#20
of 54 rated
Valuation vs. quality map
The sweet spot is upper-left: more profitable (higher ROE) for a lower P/E. Dashed lines mark the sector median.
Peers are the closest Materials companies by sub-industry and size, preferring ones with full data. Sector medians and rank use the 54 rated companies among the 78 Materials stocks we cover. Educational, not a recommendation.
5-Year Projection Model
Project revenue → earnings → price. Edit the assumptions to build your own case.
What drives this projection, and its limits2030 scenario price range (Base Case)
$62.39 – $101.39
vs. $70.66 today · implied CAGR -2% – 7%
| Metric | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| Revenue | $29.04B | $31.36B | $33.87B | $36.58B | $39.50B |
| Net income | $2.61B | $2.82B | $3.05B | $3.29B | $3.56B |
| EPS | $5.73 | $6.19 | $6.69 | $7.22 | $7.80 |
| Share price (low) | $45.86 | $49.53 | $53.49 | $57.77 | $62.39 |
| Share price (high) | $74.52 | $80.49 | $86.93 | $93.88 | $101.39 |
| CAGR (low–high) | -35% / 5% | -16% / 7% | -9% / 7% | -5% / 7% | -2% / 7% |
Educational scenario model, not a forecast or investment advice. It starts from the latest annual revenue in SEC filings. By default, growth is trailing revenue growth (held between 3% and 45% a year), the net margin is the latest one (held between 3% and 50%, so a loss-making company is modeled with a small profit), and the Base case P/E runs from 60% to 100% of today's. Carrying recent growth forward five years can miss badly in either direction. Outputs are only as good as the assumptions.
Bull Case
The case for NTR:
- Healthy free-cash-flow yield (~18.3%) funds buybacks and dividends.
- A conservative balance sheet (debt/equity 0.5x) lowers risk.
- Pays a 3.4% dividend on top of any price gains.
- Our model's overall read is Favorable (63/100).
Bear Case
The case against NTR:
- Like any single stock, it is exposed to competition, the economic cycle, and shifts in its end markets.
Key Risks
Market risk — sector rotation, the economic cycle, and broad sentiment move the stock regardless of fundamentals.
Investment Thesis
On balance, the fundamentals screen favourably: Nutrien Ltd is a large-cap materials business growing at a mature pace, with modest profitability, and a sound balance sheet. It trades at 13.1x earnings, which our model scores Favorable (63/100). Weigh this against your own goals and time horizon — this is educational information, not a recommendation.
Analyst Ratings
What 26 Wall Street analysts covering NTR recommend (September 2026). Consensus is a useful sanity check — not a substitute for your own homework.
Analysts have turned more cautious over the last three months (-4 pts of buy ratings).
Latest SEC Filings
NTR's most recent filings, straight from SEC EDGAR. Annual and quarterly reports are the deep dives; 8-Ks flag material events the moment they happen. How to read a 10-K
In the Idea Lab
NTR — frequently asked questions
Is NTR a good stock to buy?
We don't give buy or sell advice. Our model rates Nutrien Ltd Favorable (63/100) based on its growth, profitability, financial health, and valuation — use that as a research starting point and make your own decision.
What is NTR's rating on The Stocks School?
Nutrien Ltd currently scores 63/100 (Favorable) on our transparent model, which weighs real fundamentals: growth, margins, returns on capital, balance-sheet strength, and valuation.
How our ratings work →Where does NTR's data come from?
Live price data plus real fundamentals and 5-year financials pulled directly from Nutrien Ltd's SEC filings — refreshed automatically, not hand-entered.
How is the 5-year projection for NTR calculated?
It's a scenario model. It starts from the latest annual revenue and net margin in SEC filings, grows revenue at an assumed rate (trailing revenue growth by default), and applies a P/E range built around today's multiple to show the resulting share-price range. When a stock has no growth or P/E data, the starting values are placeholders. It's a tool for thinking, not a prediction.
Is this NTR analysis financial advice?
No. Everything on this page is educational research, not financial advice or a recommendation to buy or sell NTR. Always do your own research and consider a licensed professional.
Data notice. Fundamentals and financial statements are sourced from company filings (SEC EDGAR) and market-data providers; prices and market caps refresh on trading days and may be delayed. Ratings, projections, technical signals, and written summaries are model- or rule-generated for education and may simplify or lag the latest filings.
Not advice. Nothing on this page is investment advice or a recommendation to buy, hold, or sell any security. Do your own research and consult a licensed financial professional before investing.